Our studies revealed that oridonin inhibited metastatic phenotype, angiogenesis and modulated EMT in thyroid cancer in vitro and vivo through downregulation of JAK2/STAT3 signaling pathway. The gene discussed is STAT3; the disease is thyroid gland carcinoma.